Opening book details…
About this nonfiction
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial by Goldberg, Sarah B (author);Schalper, Kurt A (author);Gettinger, Scott N (author);Mahajan, Amit (author);Herbst, Roy S (author);Chiang, Anne C (author);Lilenbaum, Rogerio (author);Wilson, Frederick H (author);Omay, Sacit Bulent (author);Yu, James B (author);Jilaveanu, Lucia (author);Tran, Thuy (author);Pavlik, Kira (author);Rowen, Elin (author);Gerrish, Heather (author);Komlo, Annette (author);Gupta, Richa (author);Wyatt, Hailey (author);Ribeiro, Matthew (author);Kluger, Yuval (author);Zhou, Geyu (author);Wei, Wei (author);Chiang, Veronica L (author);Kluger, Harriet M (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Goldberg, Sarah B (author);Schalper, Kurt A (author);Gettinger, Scott N (author);Mahajan, Amit (author);Herbst, Roy S (author);Chiang, Anne C (author);Lilenbaum, Rogerio (author);Wilson, Frederick H (author);Omay, Sacit Bulent (author);Yu, James B (author);Jilaveanu, Lucia (author);Tran, Thuy (author);Pavlik, Kira (author);Rowen, Elin (author);Gerrish, Heather (author);Komlo, Annette (author);Gupta, Richa (author);Wyatt, Hailey (author);Ribeiro, Matthew (author);Kluger, Yuval (author);Zhou, Geyu (author);Wei, Wei (author);Chiang, Veronica L (author);Kluger, Harriet M (author)
- Publisher
- Elsevier BV
- Published
- 2020
- Language
- EN
- Category
- nonfiction
More by Goldberg, Sarah B (author);Schalper, Kurt A (author);Gettinger, Scott N (author);Mahajan, Amit (author);Herbst, Roy S (author);Chiang, Anne C (author);Lilenbaum, Rogerio (author);Wilson, Frederick H (author);Omay, Sacit Bulent (author);Yu, James B (author);Jilaveanu, Lucia (author);Tran, Thuy (author);Pavlik, Kira (author);Rowen, Elin (author);Gerrish, Heather (author);Komlo, Annette (author);Gupta, Richa (author);Wyatt, Hailey (author);Ribeiro, Matthew (author);Kluger, Yuval (author);Zhou, Geyu (author);Wei, Wei (author);Chiang, Veronica L (author);Kluger, Harriet M (author)
Similar books
- Pembrolizumab for Patients with Melanoma or Non-small-cell Lung Cancer and Untreated Brain Metastases: Early Analysis of a Non-randomised, Open-label, Phase 2 Trial — Goldberg, Sarah B; Gettinger, Scott N; Mahajan, Amit; Chiang, Anne C; Herbst, Roy S; Sznol, Mario; Tsiouris, Apostolos John; Cohen, Justine; Vortmeyer, Alexander; Jilaveanu, Lucia; Yu, James; Hegde, Upendra; Speaker, Stephanie; Madura, Matthew; Ralabate, Amanda; Rivera, Angel; Rowen, Elin; Gerrish, Heather; Yao, Xiaopan; Chiang, Veronica; Kluger, Harriet M (2016)
- Pembrolizumab in Brain Metastases of Diverse Histologies: Phase 2 Trial Results — Priscilla K. Brastianos & Albert E. Kim & Anita Giobbie-Hurder & Eudocia Q. Lee & Nancy U. Lin & Beth Overmoyer & Patrick Y. Wen & Lakshmi Nayak & Justine V. Cohen & Jorg Dietrich & April Eichler & Rebecca S. Heist & Ian Krop & Donald Lawrence &... (2023)
- Comparison of Two Chemotherapy Regimens in Patients with Newly Diagnosed Ewing Sarcoma (EE2012): an Open-label, Randomised, Phase 3 Trial — Brennan, Bernadette; Kirton, Laura; Marec-Bérard, Perrine; Gaspar, Nathalie; Laurence, Valerie; Martín-Broto, Javier; Sastre, Ana; Gelderblom, Hans; Owens, Cormac; Fenwick, Nicola; Strauss, Sandra; Moroz, Veronica; Whelan, Jeremy; Wheatley, Keith (2022)
- Efficacy and Safety of Fedratinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib (FREEDOM2): Results from a Multicentre, Open-label, Randomised, Controlled, Phase 3 Trial — Harrison, Claire N; Mesa, Ruben; Talpaz, Moshe; Al-Ali, Haifa Kathrin; Xicoy, Blanca; Passamonti, Francesco; Palandri, Francesca; Benevolo, Giulia; Vannucchi, Alessandro Maria; Mediavilla, Clemence; Iurlo, Alessandra; Kim, InHo; Rose, Shelonitda; Brown, Patrick; Hernandez, Christopher; Wang, Jia; Kiladjian, Jean-Jacques (2024)
- Efficacy, Immunogenicity, and Safety of a Quadrivalent HPV Vaccine in Men: Results of an Open-label, Long-term Extension of a Randomised, Placebo-controlled, Phase 3 Trial — Goldstone, Stephen E; Giuliano, Anna R; Palefsky, Joel M; Lazcano-Ponce, Eduardo; Penny, Mary E; Cabello, Robinson E; Moreira, Edson D; Baraldi, Ezio; Jessen, Heiko; Ferenczy, Alex; Kurman, Robert; Ronnett, Brigitte M; Stoler, Mark H; Bautista, Oliver; Das, Rituparna; Group, Thomas; Luxembourg, Alain; Zhou, Hao Jin; Saah, Alfred (2022)
- Patient-reported Outcomes Following Ciltacabtagene Autoleucel or Standard of Care in Patients with Lenalidomide-refractory Multiple Myeloma (CARTITUDE-4): Results from a Randomised, Open-label, Phase 3 Trial — Mina, Roberto; Mylin, Anne K; Yokoyama, Hisayuki; Magen, Hila; Alsdorf, Winfried; Minnema, Monique C; Shune, Leyla; Isufi, Iris; Harrison, Simon J; Shah, Urvi A; Schecter, Jordan M; Vogel, Martin; Lendvai, Nikoletta; Gries, Katharine S; Katz, Eva G; Slaughter, Ana; Lonardi, Carolina; Gilbert, Jane; Li, Quanlin; Deraedt, William; Filho, Octavio Costa; Patel, Nitin; Florendo, Erika; Karlin, Lionel; Weisel, Katja (2025)